Michael N. Cannizzaro is an accomplished leader in the healthcare product and services industry. His collective experiences span over 40 years in progressive and successful Director, Executive, and Senior Management roles in both publicly traded and privately held companies. He has experience at both a products and services level. His prior leadership experiences include several Fortune 50 companies. Some highlights from Mr. Cannizzaro’s career experiences include his roles as CEO of Sunrise Medical, Operating Partner at JW Childs Associates, and President of Beltone Electronics as well as roles with Caremark International, Baxter Healthcare, Leica North America, Wilson Sporting Goods, and Procter & Gamble.
Mr. Cannizzaro has a private consulting practice focusing on helping CEOs implement high performance strategies and partner in diligence processes. Prior to becoming the Chairman of the Board of Directors at Pharm-Olam, Mr. Cannizzaro was Chairman of the Board of Managers for Behavioral Health Group (BHG), a Dallas-based medication treatment and therapy company. BHG was a portfolio company of the Frontenac Company, a private equity firm based in Chicago. Mr. Cannizzaro assisted Frontenac in the pre-acquisition diligence process of BHG and, upon the successful acquisition of BHG, was appointed Chairman. Before that, he was Chairman of the Board of Directors for Sunrise Medical and the Deputy Chairman of Continental Anesthesia as well as CHG Healthcare. He was also on the Board of Crescent Healthcare.